Correlation Between Auris Medical and Denali Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Auris Medical and Denali Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Auris Medical and Denali Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Auris Medical Holding and Denali Therapeutics, you can compare the effects of market volatilities on Auris Medical and Denali Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Auris Medical with a short position of Denali Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Auris Medical and Denali Therapeutics.

Diversification Opportunities for Auris Medical and Denali Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Auris and Denali is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Auris Medical Holding and Denali Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Denali Therapeutics and Auris Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Auris Medical Holding are associated (or correlated) with Denali Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Denali Therapeutics has no effect on the direction of Auris Medical i.e., Auris Medical and Denali Therapeutics go up and down completely randomly.

Pair Corralation between Auris Medical and Denali Therapeutics

If you would invest  2,366  in Denali Therapeutics on December 30, 2023 and sell it today you would lose (314.00) from holding Denali Therapeutics or give up 13.27% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Auris Medical Holding  vs.  Denali Therapeutics

 Performance 
       Timeline  
Auris Medical Holding 

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Auris Medical Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Auris Medical is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.
Denali Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Low
 
High
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Denali Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong essential indicators, Denali Therapeutics is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders.

Auris Medical and Denali Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Auris Medical and Denali Therapeutics

The main advantage of trading using opposite Auris Medical and Denali Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Auris Medical position performs unexpectedly, Denali Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Denali Therapeutics will offset losses from the drop in Denali Therapeutics' long position.
The idea behind Auris Medical Holding and Denali Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios